Literature DB >> 17984387

The transforming growth factor-beta/Smad3 pathway: coming of age as a key participant in cardiac remodeling.

David Seo, Joshua M Hare.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984387     DOI: 10.1161/CIRCULATIONAHA.107.735381

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1/Smad2 expression.

Authors:  Jian-Gui He; Sheng-Long Chen; Yi-Yi Huang; Yi-Li Chen; Yu-Gang Dong; Hong Ma
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

2.  Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Mark D Handschumacher; Suzanne Sullivan; Benjamin Johnson; James S Titus; Yoshiko Iwamoto; Jill Wylie-Sears; Robert A Levine; Alain Carpentier
Journal:  Circulation       Date:  2009-07-13       Impact factor: 29.690

Review 3.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

4.  Sang-qi Granula Reduces Blood Pressure and Myocardial Fibrosis by Suppressing Inflammatory Responses Associated with the Peroxisome Proliferator-Activated Receptors and Nuclear Factor κ B Protein in Spontaneously Hypertensive Rats.

Authors:  Lan-Yu Chen; Chun-Shui Pan; Xiao-Hong Wei; Lin Li; Jing-Yan Han; Li Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-22       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.